SCHEMBL936482

SCHEMBL936482

COC(=O)c1cc(CCl)cc(N(C)S(=O)(=O)c2ccc(OCc3ccccc3)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MMP13 P45452 3/20 0.48
MMP9 P14780 2/20 0.48
ADAM17 P78536 1/20 0.48
ALDH1A1 P00352 2/20 0.46
POLB P06746 2/20 0.46
MMP2 P08253 2/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
ADAMTS4 O75173 2/20 0.46
MMP14 P50281 1/20 0.46
ADAMTS5 Q9UNA0 1/20 0.46
KEAP1 Q14145 1/20 0.44
NOX1 Q9Y5S8 1/20 0.44
PTGES O14684 3/20 0.44
KCNH2 Q12809 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL935987 0.93 MEN1 (0.50) MEN1KMT2AMMP13MMP9ADAM17
SCHEMBL935375 0.92 MEN1 (0.54) MEN1KMT2AMMP13MMP9ADAM17
SCHEMBL935593 0.89 MEN1 (0.52) MEN1KMT2AMMP13MMP9ADAM17
SCHEMBL12944627 0.86 ALDH1A1 (0.49) MEN1KMT2AMMP13MMP9ADAM17
SCHEMBL935631 0.82 NPC1 (0.43) MEN1KMT2AMMP13MMP9ADAM17
SCHEMBL935376 0.79 KMT2A (0.50) MEN1KMT2AMMP13MMP9ADAM17
SCHEMBL12944633 0.79 ALDH1A1 (0.50) MEN1KMT2AMMP13MMP9ADAM17
SCHEMBL8250781 0.77 HTT (0.54) MEN1KMT2AALDH1A1POLBLMNA
SCHEMBL662376 0.77 MEN1 (0.65) MEN1KMT2APOLBKEAP1NOX1
SCHEMBL12944623 0.76 MMP1 (0.53) MEN1KMT2AMMP13MMP9ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470860-B2 Phenyl-sulfamates as aromatase inhibitors STERIX LIMITED (GB) 2013-06-25 US disclosed
US-20110021586-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX, LIMITED (GB) 2011-01-27 US disclosed
US-7763642-B2 Phenyl-sulfamates as aromatase inhibitors STERIX LTD. (GB) 2010-07-27 US disclosed
US-7763642-B2 Phenyl-sulfamates as aromatase inhibitors STERIX LTD. (GB) 2010-07-27 US disclosed
EP-1753732-B1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX LTD (GB) 2009-12-02 EP disclosed
US-20070117855-A1 Phenyl-sulfamates as aromatase inhibitors STERIX LIMITED (GB) 2007-05-24 US disclosed
US-20070117855-A1 Phenyl-sulfamates as aromatase inhibitors STERIX LIMITED (GB) 2007-05-24 US disclosed
EP-1753732-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS Sterix Limited (GB) 2007-02-21 EP disclosed
WO-2005118560-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX LIMITED (GB) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117855-A1 Phenyl-sulfamates as aromatase inhibitors CYP19A1, CYP17A1, CYP21A2 MEN1 3186/4885KMT2A 907/4885MMP13 1566/4885
US-20110021586-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS CYP19A1, CYP17A1, CYP21A2 MEN1 3186/4885KMT2A 907/4885MMP13 1566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.